Company

Vision

About Doctor Haruhiko Inufusa

Create innovative products to contribute to the health and future of people around the world.

Message from the CEO

With the extension of human life, we are entering an era known as “100 years of life”.
However, how to prolong the “healthy life” that enables us to live a healthy life has become a major topic for us to live in the “100 year era of life”. 。

The company was founded by Haruhiko Fang, a former Kinki University professor and surgeon (now a special professor at Gifu University), who focused on “oxidative stress” as the cause of aging and more than 150 diseases, so he began basic research. After that, antioxidant substances with vitamins and amino acids were successfully developed. After the effectiveness test, safety test, patent certification and other procedures, it can be put into production.

At present, it is also conducting joint research with research institutions and researchers at home and abroad to carry out clinical trials and monitoring tests on patients with various diseases, and it will also be published in papers and societies in the future.

We hope to provide products with medical basis to realize the condition that has not caused disease attack but is far away from health. We will make serious efforts to contribute to the health and longevity of more people.

SUPALIV INC.
TIMA TOKYO INC.
CEO　Sho Tanaka

About Doctor Haruhiko Inufusa

Haruhiko Inufusa

Doctor,M.D.
Antioxidant Laboratory, Louis Pasteur Medical Research Center,Presidential Researcher
Antioxidant Research Department,Joint Research Lecture,Gifu University Research Foundation Center,Distinguished Professor
TIMA establishment Chief Researcher
Japan Society for the Prevention of Cognitive Dysfunction,Certification Creation Committee,Executive Committee Member
Director of Japan brain nutrition supplementary food association

Resume

He graduated from the Department of medicine of Kinki University in 1982. He graduated from the Department of surgery (medical doctor) of the Graduate School of medicine, Kinki University in 1988. Major in gastrointestinal surgery, laparoscopic surgery and cancer metastasis research. After retiring from Kinki University, he began to study oxidative stress, glucose and lipid metabolism in 2007 as the CEO researcher of the medical consortium TIMA establishment. In 2013, he became a special professor at the founding of the antioxidant research department of the joint research lecture of the basic scientific research center of Gifu University. In 2020, he became (concurrently) the CEO researcher of the antioxidant research office of Louis Pasteur medical research center, a public welfare consortium legal person. Now carry out research on oxidative stress and antioxidant formula “Tweedee X”. Health series of 55000 registrants YouTube “antioxidant channel” transmission
url: https://www.youtube.com/channel/UCqLUacXBk84-VsGas0syFHQ

TIMA establishment

Location	Alte Churer Strasse 45 FL-9496 Balzers Liechtenstein
CEO	Markus Count Matuschka de Greiffenclau
Chair Research	Haruhiko Inufusa

SUPALIV INC.

Tokyo head office

Date of establishment	June 1, 2015 (*The predecessor company was established on December 1, 2006)
Representative	CEO　Sho Tanaka
Location	・Tokyo head office 〒150-0013　 3rd Floor, SP15EBISU, 3-28-2, Ebisu 3, Shibuya-ku, Tokyo ・Osaka Branch 〒542-0081　 No. 1-404, 1-404, Minami Shipba, Chuo-ku, Osaka-shi, Osaka Prefecture, 542-0081
Capital	21 million yen
Major shareholders	TIMA establishment
Business content	Production and sales of SPALIV

TIMA Tokyo Inc.

Osaka Branch

Date of establishment	June 21, 2019
Representative	CEO Sho Tanaka
Location	・Tokyo head office 〒150-0013　 3rd Floor, SP15EBISU, 3-28-2, Ebisu 3, Shibuya-ku, Tokyo ・Osaka Branch 〒542-0081　 No. 1-404, 1-404, Minami Shipba, Chuo-ku, Osaka-shi, Osaka Prefecture
Capital	8 million yen
Major shareholders	TIMA establishment
Business content	Production and sales of Oxicut, production and sales of Mtcontrol

Research Office

Antiacidification Laboratory of Louis Pasteur Medical Research Center
〒606-8225 103-5 Tanaka Monzen-cho, Sakyo-ku, Kyoto City
https://antioxidantres.jp/

Tokai National University Institution Gifu University Institute for Advanced Study Research Foundation Center
Joint Research Lecture Antioxidant Research Department
〒501-1194 Inside the building of the Faculty of Medicine, Gifu University, 1-1 Yanaido, Gifu City, Gifu Prefecture
https://www1.gifu-u.ac.jp/~lsrc/staff/staff_anti.html

Directors

TIMA establishment

Markus Count Matuschka de Greiffenclau

CEO

Since 1990, he has provided investment and business consulting services to Skype and other companies. Since 2005, the TIMA establishment has been established for the purpose of donating medical research and served as the CEO.
Currently, centered on biotechnology, the company is engaged in various investment operations including “Lysando（http://www.lysando.com）”, a company that owns patents such as antimicrobial drugs that do not cause drug resistance.

Haruhiko Inufusa

Chief Researcher

Born in Okayama Prefecture, graduated from the Faculty of Medicine of Kinki University with a doctor of medicine.
After that, he successively served as a professor in the Department of Clinical Medicine, Faculty of Medicine, Kinki University, a visiting professor at the European Institute of Telesurgery at the University of Strasbourg, and a visiting professor at the surgical classroom at the University of Barcelona, Spain. In December 2006, he founded SUPALIV INC. Founding of a company), since 2013, he has been a special professor in the Antioxidant Research Department of Gifu University. In 2020, he will serve as (concurrently) the CEO and researcher of the Antioxidant Research Office of the Louis Pasteur Medical Research Center.

SUPALIV INC. TIMA Tokyo Inc.

Sho Tanaka

CEO

Born in Kyoto Prefecture, graduated from Chuo University.
After graduating from university, he started investing and managing education and human resources in Japan and Southeast Asian countries in 2007.
Since 2015, he has participated in the planning as an operating member of the company.

Yohei Tsukamoto

Director

Raised in the Republic of South Africa and the UK, graduated from Kobe City University of Foreign Studies.
Established a system development company in 2011 after conducting domestic and foreign business development at Fujitsu Co., Ltd. and MISUMI Co., Ltd.
Since 2015, he has participated in the planning as an operating member of the company.

Adviser

Toshikazu Yoshikawa

President of the Louis Pasteur Medical Research Center
Honorary President of Japan Society for Oxidative Stress
Honorary President of Japan Anti-Aging Medicine Association

Taku Nakashima

Department of Respiratory Medicine, Hiroshima University Hospital

Helmut Durchschlag

Ph.D., Institute of Radiation Physics and Physical Biochemistry, University of Regensburg

Christian Amatore

Professor of the French Academy of Sciences (member of the French Academy)

Koji Fukui

Professor of Molecular and Cell Biology Laboratory, Department of Life Sciences, Faculty of Systems Engineering, Shibaura Institute of Technology

Development history

January 2001	Establishment of a TIMA establishment (Liechtenstein) for the purpose of medical research and development
June 2005	At present, Markus Matuschka v.Greiffenclau takes office as Director General of the TIMA establishment (Liechtenstein)
November 2006	At present, Haruhiko Inufusa is appointed as the President and Researcher of TIMA establishment (Liechtenstein)
November 2006	Brookfield Medical Co., Ltd. (now TIMA TOKYO INC., SUPALIV INC.) was established for the purpose of research and development by the research team led by Haruhiko Inufusa.
November 2010	Launched “SUPALIV”, a nutritional supplement for alcohol metabolism
September 2013	Sales of “SUPALIV” started at FamilyMart nationwide
November 2013	Haruhiko Inufusa is appointed as a Distinguished Professor of the Antioxidant Research Department of Gifu University
December 2017	The cumulative sales of “SUPALIV” exceeded 3 million
August 2019	TIMA TOKYO INC. was established for the purpose of production and sales business on the occasion of the official launch of the nutritional supplement “Oxicut” (academic name: Twendee X), which was born from antioxidant research.
November 2019	The cumulative sales of “SUPALIV” exceeded 4 million units, and the Japanese Society for the Prevention of Cognitive Dysfunction recognized “Twendee X” as Grade A
July 2020	Launched the mitochondrial nutritional supplement “Mtcontrol”
April 2021	The cumulative sales of “SUPALIV” exceeded 5 million